全文获取类型
收费全文 | 3208篇 |
免费 | 216篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 115篇 |
妇产科学 | 101篇 |
基础医学 | 384篇 |
口腔科学 | 68篇 |
临床医学 | 323篇 |
内科学 | 771篇 |
皮肤病学 | 79篇 |
神经病学 | 189篇 |
特种医学 | 70篇 |
外科学 | 400篇 |
综合类 | 79篇 |
一般理论 | 5篇 |
预防医学 | 230篇 |
眼科学 | 85篇 |
药学 | 278篇 |
中国医学 | 14篇 |
肿瘤学 | 223篇 |
出版年
2024年 | 5篇 |
2023年 | 41篇 |
2022年 | 111篇 |
2021年 | 162篇 |
2020年 | 87篇 |
2019年 | 135篇 |
2018年 | 175篇 |
2017年 | 84篇 |
2016年 | 105篇 |
2015年 | 96篇 |
2014年 | 139篇 |
2013年 | 204篇 |
2012年 | 270篇 |
2011年 | 210篇 |
2010年 | 141篇 |
2009年 | 116篇 |
2008年 | 169篇 |
2007年 | 191篇 |
2006年 | 185篇 |
2005年 | 149篇 |
2004年 | 133篇 |
2003年 | 103篇 |
2002年 | 82篇 |
2001年 | 32篇 |
2000年 | 34篇 |
1999年 | 26篇 |
1998年 | 14篇 |
1997年 | 15篇 |
1996年 | 12篇 |
1995年 | 4篇 |
1994年 | 8篇 |
1993年 | 8篇 |
1992年 | 20篇 |
1991年 | 15篇 |
1990年 | 16篇 |
1989年 | 8篇 |
1988年 | 13篇 |
1987年 | 13篇 |
1986年 | 15篇 |
1985年 | 15篇 |
1984年 | 6篇 |
1983年 | 7篇 |
1981年 | 10篇 |
1980年 | 7篇 |
1979年 | 6篇 |
1978年 | 4篇 |
1976年 | 3篇 |
1973年 | 8篇 |
1972年 | 3篇 |
1971年 | 5篇 |
排序方式: 共有3434条查询结果,搜索用时 10 毫秒
51.
52.
Robert A. Chong Kenneth Wu Donald E. Spratt Yingying Yang Chan Lee Jaladhi Nayak Ming Xu Rana Elkholi Inger Tappin Jessica Li Jerard Hurwitz Brian D. Brown Jerry Edward Chipuk Zhijian J. Chen Roberto Sanchez Gary S. Shaw Lan Huang Zhen-Qiang Pan 《Proceedings of the National Academy of Sciences of the United States of America》2014,111(23):8434-8439
Lysine 48 (K48)-polyubiquitination is the predominant mechanism for mediating selective protein degradation, but the underlying molecular basis of selecting ubiquitin (Ub) K48 for linkage-specific chain synthesis remains elusive. Here, we present biochemical, structural, and cell-based evidence demonstrating a pivotal role for the Ub Y59-E51 loop in supporting K48-polyubiquitination. This loop is established by a hydrogen bond between Ub Y59’s hydroxyl group and the backbone amide of Ub E51, as substantiated by NMR spectroscopic analysis. Loop residues Y59 and R54 are specifically required for the receptor activity enabling K48 to attack the donor Ub-E2 thiol ester in reconstituted ubiquitination catalyzed by Skp1-Cullin1-F-box (SCF)βTrCP E3 ligase and Cdc34 E2-conjugating enzyme. When introduced into mammalian cells, loop-disruptive mutant UbR54A/Y59A diminished the production of K48-polyubiquitin chains. Importantly, conditional replacement of human endogenous Ub by UbR54A/Y59A or UbK48R yielded profound apoptosis at a similar extent, underscoring the global impact of the Ub Y59-E51 loop in cellular K48-polyubiquitination. Finally, disulfide cross-linking revealed interactions between the donor Ub-bound Cdc34 acidic loop and the Ub K48 site, as well as residues within the Y59-E51 loop, suggesting a mechanism in which the Ub Y59-E51 loop helps recruit the E2 acidic loop that aligns the receptor Ub K48 to the donor Ub for catalysis.Central to selective protein turnover by the 26S proteasome is the formation of homotypic lysine 48 (K48)-linked ubiquitin (Ub) chains that tag substrate proteins for degradation (1). Among the most extensively studied systems that produce K48-linked Ub chains is the SCF (Skp1-Cullin1-F-box) E3-directed ubiquitination. SCF is a member of the multisubunit Cullin-RING E3 Ub ligase (CRL) family, the largest of all E3s (2). CRL contains a tandem of a large scaffold protein [Cullin (CUL)] and a RING domain-containing protein (ROC1/Rbx1) that typically associates with an adaptor protein (such as Skp1) in complex with a substrate recognition protein (such as F-box protein). As such, the organization of CRL subunits positions the substrate receptor (such as the F-box protein) within the proximity of ROC1, which recruits an E2-conjugating enzyme that catalyzes the transfer of Ub to a bound substrate. In the SCF reconstitution system, K48-linked polyubiquitin chains on a substrate such as IκBα and β-catenin are produced in a two-step reaction. The E2 UbcH5c deposits the first Ub moiety, forming a substrate–Ub linkage, which is followed by repeated discharge of subsequent Ubs by E2 Cdc34 to form K48-specific Ub chains (3). Human Cdc34 contains a highly conserved charged acidic loop (residues 102–113) that participates in the elongation of K48 chains (4, 5). The current work addresses whether there are determinants on the Ub itself that dictate K48 linkage specificity and, moreover, how Cdc34 might recognize Ub K48. 相似文献
53.
54.
55.
56.
57.
58.
59.
60.
Cevik A Kula S Olgunturk R Tunaoglu FS Oguz AD Pektas A Saylan B 《Echocardiography (Mount Kisco, N.Y.)》2012,29(7):840-848
Introduction and Objective: The present study aims to quantitatively evaluate the right ventricle (RV) function by means of transthoracic echocardiography in normal children and childhood congenital heart disease patients with pulmonary hypertension. Patients and Methods: This study was conducted in a cohort including 40 healthy children and 30 pediatric patients with pulmonary hypertension who were diagnosed under close surveillance at the study center between October 2009 and November 2010. Results: Statistically significant differences were found between the patient and control groups for the right ventricle myocardial performance index (RVMPI), the left ventricle myocardial performance index (LVMPI), the tricuspid valve systolic flow velocity (Ts), the ratio of systolic pulmonary artery pressure to the right ventricle outflow tract systolic flow velocity time integral (sPAP/RVOT VTI), and the ratio of systolic pulmonary artery pressure to right ventricle outflow tract systolic flow velocity time integral × heart rate (sPAP/[RVOT VTI×HR]). When the children were divided into three groups based on their pulmonary vascular resistance significant differences emerged that predicted an increasing severity of RV dysfunction. Significant differences were also observed for the RVMPI, the LVMPI, and the Ts as well as for echocardiographic pulmonary flow (Qp) and systemic flow (Qs). Discussion: The present study demonstrates that echocardiographic parameters can be used for the quantitative detection of RV dysfunction in childhood congenital heart disease patients with high pulmonary artery pressure (systolic, diastolic, and mean) or pulmonary vascular resistance. 相似文献